Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy (Q81436256)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Teresa Cabrera

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

8

Federico Garrido

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Rafael Carretero

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

José M Romero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Francisco Ruiz-Cabello

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Isabel Maleno

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Felix Rodriguez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Francisco M Camacho

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

1 reference

11 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

439-447

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18545995%20AND%20SRC:MED&resulttype=core&format=json

MHC class I antigens and immune surveillance in transformed cells.

8 January 2020

cites work

1 reference

12 December 2020

Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products

1 reference

12 December 2020

MHC antigens and tumor escape from immune surveillance

1 reference

12 December 2020

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

12 December 2020

Gene-based vaccines and immunotherapeutics

1 reference

12 December 2020

Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy

1 reference

12 December 2020

HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.

1 reference

12 December 2020

M-Vax: an autologous, hapten-modified vaccine for human cancer

1 reference

12 December 2020

Role of altered expression of HLA class I molecules in cancer progression.

1 reference

12 December 2020

Challenges in the development of effective peptide vaccines for cancer

1 reference

12 December 2020

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

1 reference

12 December 2020

Total loss of MHC class I is an independent indicator of good prognosis in breast cancer

1 reference

12 December 2020

Biological and clinical developments in melanoma vaccines

1 reference

12 December 2020

Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131.

1 reference

12 December 2020

Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants

1 reference

12 December 2020

Escape from immunotherapy: possible mechanisms that influence tumor regression/progression.

1 reference

12 December 2020

Role of the interferon-stimulated response element in HLA-B downregulation in human melanoma cell lines

1 reference

12 December 2020

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen

1 reference

12 December 2020

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction

1 reference

12 December 2020

High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis

1 reference

12 December 2020

Cancer immunotherapy: moving beyond current vaccines

1 reference

12 December 2020

Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma

1 reference

12 December 2020

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

12 December 2020

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

1 reference

12 December 2020

Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines

1 reference

12 December 2020

Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines

1 reference

12 December 2020

Selection of metastatic tumour phenotypes by host immune systems

1 reference

12 December 2020

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

1 reference

12 December 2020

Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors

1 reference

12 December 2020

Cytokine therapeutics: lessons from interferon alpha

1 reference

12 December 2020

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

1 reference

12 December 2020

Identification of the amino acid residues defining an intralocus determinant in the alpha 1 domain of HLA-A molecules

1 reference

12 December 2020

Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?

1 reference

12 December 2020

Tumour immunology: MHC antigens and malignancy

1 reference

12 December 2020

A single polymorphic residue within the peptide-binding cleft of MHC class I molecules determines spectrum of tapasin dependence

1 reference

12 December 2020

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

1 reference

12 December 2020

Cancer despite immunosurveillance: immunoselection and immunosubversion

1 reference

12 December 2020

Loss of HLA haplotype and B locus down-regulation in melanoma cell lines

1 reference

12 December 2020

LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas

1 reference

12 December 2020

Biochemical and serological characterization of a public antigenic determinant present on HLA-B molecules.

1 reference

12 December 2020

Vaccine therapy for melanoma: current status and future directions

1 reference

12 December 2020

Interferon-alpha (IFN-alpha) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation in mixed lymphocyte tumour cultures (MLTC)

1 reference

12 December 2020

HLA class I antigen abnormalities and immune escape by malignant cells.

1 reference

12 December 2020

Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line.

1 reference

12 December 2020

HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas

1 reference

12 December 2020

Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific

1 reference

12 December 2020

1 reference

12 December 2020